Nervgen Pharma NGEN
NASDAQ NGEN
$1.35 +0.02 (+1.50%)
At close: Nov 11, 2026 · 4:00 PM EST

Nervgen Pharma (NGEN) Enterprise Value (2024 - 2026)

Updated

Nervgen Pharma (NGEN) posted Enterprise Value of $103 million for Q2 2026, down 41.9% from $177.24 million a year earlier and down 64.3% from the prior quarter.

Analysis

Nervgen Pharma (NGEN) Enterprise Value (2024 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Enterprise Value at Nervgen Pharma was $62.96 million; for FY2025, it was $429.92 million, up 204.3% from FY2024.

  • In prior years, Nervgen Pharma's Enterprise Value was $141.29 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Nervgen Pharma 105.93 Mn 4.82 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 103.00 Mn
Mar 31, 2026 288.39 Mn
Dec 31, 2025 429.92 Mn
Jun 30, 2025 177.24 Mn
Mar 31, 2025 140.67 Mn
Dec 31, 2024 141.29 Mn
API Access

Nervgen Pharma Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=NGEN&period=max&api_key=YOUR_API_KEY